Waiting Time Intervals for Non-small Cell Lung Cancer Diagnosis and Treatment in Alberta: Quantification of Intervals and Identification of Risk Factors Associated with Delays

Clinical Oncology

Volumn 28, Issue 12, 2016, Pages 750-759

  Kim, J O A ^a   Davis, F ^a   Butts, C ^a   Winget, M ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Delays; diagnostic waiting time intervals; non small cell lung cancer; risk factors; treatment waiting time intervals

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ALBERTA; ARTICLE; CANADA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HOSPITAL PATIENT; HUMAN; LARGE CELL LUNG CARCINOMA; LUNG ADENOCARCINOMA; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON SMALL CELL LUNG CANCER; OUTPATIENT DEPARTMENT; PHYSICIAN; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL LUNG CARCINOMA; TIME; VERY ELDERLY; CARCINOMA, NON-SMALL-CELL LUNG; DELAYED DIAGNOSIS; LUNG NEOPLASMS; PROTOCOL COMPLIANCE; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

AGED; ALBERTA; CARCINOMA, NON-SMALL-CELL LUNG; DELAYED DIAGNOSIS; FEMALE; GUIDELINE ADHERENCE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 84992455337     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2016.06.010     Document Type: Article

References (23)

1. [1] Canadian Partnership Against Cancer, Lung Cancer in Canada: a Supplemental System Performance Report., 2010.
2. [2] Canadian Cancer Society's Advisory Committee on Cancer Statistics. Canadian Cancer Statistics 2014.
3. [3] O'Rourke, N., Edwards, R., Lung cancer treatment waiting times and tumour growth. Clin Oncol 12 (2000), 141–144.
4. [4] Risberg, T., Sorbye, S.W., Norum, J., Wist, E.A., Diagnostic delay causes more psychological distress in female than in male cancer patients. Anticancer Res 16 (1996), 995–999.
5. [5] Jakobsen, E., Green, A., Oesterlind, K., Rasmussen, T.R., Iachina, M., Palshof, T., Nationwide quality improvement in lung cancer care: the role of the Danish Lung Cancer Group and Registry. J Thorac Oncol 8 (2013), 1238–1247.
6. [6] Romanow, R., Building on values: the future of health care in Canada. 2002 http://publications.gc.ca/collections/Collection/CP32-85-2002E.pdf.
7. [7] Coleman, M.P., Forman, D., Bryant, H., et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377 (2011), 127–138.
8. [8] Tucker, T.C., Howe, H.L., Weir, H.K., Certification for population-based cancer registries. J Reg Mgmt 26 (1999), 24–27.
9. [9] Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987), 373–383.
10. [10] Sundararajan, V., Henderson, T., Perry, C., Muggivan, A., Quan, H., Ghali, W.A., New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 57 (2004), 1288–1294.
11. [11] Walter, F., Webster, A., Scott, S., Emery, J., The Andersen model of total patient delay: a systematic review of its application in cancer diagnosis. J Health Serv Res Policy 17 (2012), 110–118.
12. [12] Weller, D., Vedsted, P., Rubin, G., et al. The Aarhus statement: improving design and reporting of studies on early cancer diagnosis. Br J Cancer 106 (2012), 1262–1267.
13. [13] Alberta Health Services, Program to deliver faster treatment for lung cancer patients. 2011.
14. [14] BTS recommendations to respiratory physicians for organising the care of patients with lung cancer, The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 53:Suppl. 1 (1998), S1–S8.
15. [15] Alberts, W.M., Bepler, G., Hazelton, T., Ruckdeschel, J.C., Williams, J.H. Jr., American College of Chest Physicians. Lung cancer. Practice organization. Chest 123 (2003), 332S–337S.
16. [16] Hunnibell, L.S., Rose, M.G., Connery, D.M., et al. Using nurse navigation to improve timeliness of lung cancer care at a veterans’ hospital. Clin J Oncol Nurs 16 (2012), 29–36.
17. [17] Leary, A., Corrigan, P., Redesign of thoracic surgical services within a cancer network-using an oncology focus to inform change. Eur J Oncol Nurs 9 (2005), 74–78.
18. [18] Neal, R.D., Din, N.U., Hamilton, W., et al. Comparison of cancer diagnostic intervals before and after implementation of NICE guidelines: analysis of data from the UK General Practice Research Database. Br J Cancer 110 (2014), 584–592.
19. [19] Lo, D.S., Zeldin, R.A., Skrastins, R., et al. Time to treat: a system redesign focusing on decreasing the time from suspicion of lung cancer to diagnosis. J Thorac Oncol 2 (2007), 1001–1006.
20. [20] Rivera, M.P., Mehta, A.C., Wahidi, M.M., Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd edn. American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143, 2013 e142S–165S.
21. [21] Crawford, S.C., Davis, J.A., Siddiqui, N.A., et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. Br Med J, 325, 2002, 196.
22. [22] Gavrielov-Yusim, N., Friger, M., Use of administrative medical databases in population-based research. J Epidemiol Community Health 68 (2014), 283–287.
23. [23] Li, X., Hilsden, R., Hossain, S., Fleming, J., Winget, M., Validation of administrative data sources for endoscopy utilization in colorectal cancer diagnosis. BMC Health Serv Res, 12, 2012, 358.